HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vivek Kapur Selected Research

Paratuberculosis (Johne's Disease)

3/2022Immunological Evaluation of Goats Immunized with a Commercial Vaccine against Johne's Disease.
11/2019Identification of Sero-Diagnostic Antigens for the Early Diagnosis of Johne's Disease using MAP Protein Microarrays.
7/2017Identification of Novel Seroreactive Antigens in Johne's Disease Cattle by Using the Mycobacterium tuberculosis Protein Array.
1/2017Identification of sero-reactive antigens for the early diagnosis of Johne's disease in cattle.
1/2014Screening of Mycobacterium avium subsp. paratuberculosis mutants for attenuation in a bovine monocyte-derived macrophage model.
1/2014Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.
1/2014Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease.
1/2014A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.
7/2012MAP1272c encodes an NlpC/P60 protein, an antigen detected in cattle with Johne's disease.
2/2008Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vivek Kapur Research Topics

Disease

27Infections
03/2022 - 04/2003
22Paratuberculosis (Johne's Disease)
03/2022 - 04/2002
6COVID-19
04/2021 - 06/2020
4Bovine Tuberculosis
01/2022 - 01/2019
3Tuberculosis (Tuberculoses)
01/2020 - 12/2005
2Virus Diseases (Viral Diseases)
04/2021 - 01/2021
2Disease Progression
01/2017 - 01/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2007 - 05/2002
2Septic Shock (Toxic Shock Syndrome)
04/2002 - 02/2002
1Breakthrough Infections
02/2022
1Coronavirus Infections
01/2021
1Hemolytic-Uremic Syndrome
01/2021
1Diarrhea
01/2021
1Zoonoses
12/2019
1Critical Illness (Critically Ill)
01/2016
1Pathologic Processes
12/2013
1Crohn Disease (Crohn's Disease)
01/2008
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2007
1Meningeal Tuberculosis (Tuberculous Meningitis)
12/2005
1Sudden Infant Death (SID)
03/2004
1Starvation
12/2002
1Scarlet Fever
04/2002

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
04/2021 - 04/2002
12AntigensIBA
01/2022 - 01/2004
8VaccinesIBA
03/2022 - 05/2002
5DNA (Deoxyribonucleic Acid)IBA
01/2008 - 04/2002
4Recombinant ProteinsIBA
07/2017 - 01/2007
3Neutralizing AntibodiesIBA
02/2022 - 01/2021
3Indicators and Reagents (Reagents)IBA
01/2020 - 04/2002
3Membrane Proteins (Integral Membrane Proteins)IBA
07/2012 - 03/2004
3Complementary DNA (cDNA)IBA
01/2005 - 04/2003
2Angiotensin-Converting Enzyme 2IBA
04/2021 - 01/2021
2AntibodiesIBA
01/2021 - 02/2008
2Immunoglobulin G (IgG)IBA
12/2020 - 06/2020
2ProteomeIBA
07/2017 - 01/2017
2Staphylococcus aureus RNAIIIIBA
01/2008 - 02/2002
2IronIBA
10/2007 - 12/2002
2CytokinesIBA
11/2006 - 12/2005
2NucleotidesIBA
08/2005 - 05/2003
2Virulence Factors (Pathogenicity Factors)IBA
08/2005 - 02/2002
1Viral RNAIBA
02/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1Attenuated VaccinesIBA
10/2021
1Shiga Toxin (Shigella Toxin)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2018
1Inactivated VaccinesIBA
01/2014
1Pharmaceutical PreparationsIBA
12/2013
1Lipoproteins (Lipoprotein)IBA
07/2012
1Ribosomal DNA (rDNA)IBA
01/2011
1Codon (Codons)IBA
03/2010
1Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2008
1Cell ExtractsIBA
05/2007
1Interleukin-6 (Interleukin 6)IBA
11/2006
1NF-kappa B (NF-kB)IBA
11/2006
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2006
1LigandsIBA
11/2006
1Protein Kinases (Protein Kinase)IBA
11/2006
1Mitogen-Activated Protein KinasesIBA
11/2006
1Chemokine ReceptorsIBA
11/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2005
1ChemokinesIBA
12/2005
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2005
1mycobactinsIBA
08/2005
1Ligases (Synthetase)IBA
08/2005
1Adenosine Monophosphate (AMP)IBA
08/2005
1RNA (Ribonucleic Acid)IBA
06/2005
1InterferonsIBA
01/2005
1Recombinant Fusion ProteinsIBA
06/2004
1SiderophoresIBA
03/2004
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2004
1Polytetrafluoroethylene (Teflon)FDA Link
03/2004
14-(N-maleimido)benzyltrimethylammonium (MPTA)IBA
03/2004
1Chemotactic FactorsIBA
04/2003
1Complement System Proteins (Complement)IBA
04/2003
1Vincristine (Oncovin)FDA LinkGeneric
05/2002
1Paclitaxel (Taxol)FDA LinkGeneric
05/2002
1Streptococcus pyogenes SpeA proteinIBA
04/2002
1ExotoxinsIBA
04/2002

Therapy/Procedure

5Therapeutics
04/2021 - 12/2005
1Immunotherapy
01/2021